Results 181 to 190 of about 1,180,314 (222)
Development of VP30-targeted nanoparticles using DPS4 fusion peptides for the inhibition of Ebola virus. [PDF]
J NanobiotechnologyWu F, Huang Y, Li R, Gao P, Lv P, Wu G, Ma Y, Ding Q, Zhong J, Su J, Xu W. +10 moreeuropepmc +1 more sourceFive-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease
Beavogui AH, Doumbia S, Kieh M, Leigh B, Sow S, Lhomme E, Ben-Farhat S, Dubois Cauwelaert N, Roy C, Diouf W, Idrissa S, Diarra S, Millimouno NP, Diallo FA, Kamara M, Pratt D, Dicko I, Kennedy SB, Espérou H, Choi EM, Kpetigo AD, D’Ortenzio E, Diallo A, Lancrey-javal S, Hamzé B, Schwimmer C, Wiedemann A, Ayouba A, Peeters M, Lane HC, Higgs E, Watson-Jones D, Yazdanpanah Y, Greenwood B, Richert L, Levy Y, PREVAC study Team. +36 moreeuropepmc +1 more sourcePhylogenetic analysis of initial Ebola virus genomes from the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo, September 2025
Wawina-Bokalanga T, Amuri A, Luakanda G, Makangara-Cigolo J, Kinganda-Lusamaki E, Ngandu C, Bula-Loso S, Mossoko M, Tshulo L, Akil-Bandali P, Kitenge R, Brosius I, Lokilo E, Kimbonza S, Paku-Tshambu P, Ngonda-Tshibinda A, Kuispond-Swar N, Ayouba A, Nsio J, Mbantshi-Beya J, Cikaya-Kankolongo F, Ntumba-Tshitenge O, Keita M, Mukadi P, Mukadi-Bamuleka D, Tshiani-Mbaya O, Mulangu S, Quick J, Loman N, O’Toole Á, Mwamba D, Delaporte E, Hensley L, Rimoin A, Wilkinson S, Peeters M, Ahuka-Mundeke S, Liesenborghs L, Kindrachuk J, Low N, Carroll M, Maes P, Vercauteren K, Muyembe-Tamfum J, Kuppalli K, Rambaut A, Wawina-Bokalanga T, Mbala P. +47 moreeuropepmc +1 more source